Back to search

France· FR:65527071

ZUTECTRA 500 UI, solution injectable en seringue préremplie

A medicinal product containing immunoglobuline humaine de l'hépatite b, registered in France by BIOTEST PHARMA (ALLEMAGNE).

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedZUTECTRA 500 UI, solution injectable …ATC—REGISTER NO.FR:65527071PACKS LISTED1CHECKEDSeptember 12, 2026

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
IMMUNOGLOBULINE HUMAINE DE L'HÉPATITE B
Manufacturer
BIOTEST PHARMA (ALLEMAGNE)
Country
France (FR)
ATC code
—
Reimbursed
No
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

  • cip13
    3400957875718
    5 seringue(s) préremplie(s) en verre de 1 ml

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f9ddc47a-97fc-49eb-95cd-34558183f94d
GET /v1/drugs/f9ddc47a-97fc-49eb-95cd-34558183f94d?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "65527071",
  "date_amm": "2009-11-30",
  "type_amm": "Procédure centralisée",
  "numero_ue": "EU/1/09/600",
  "substance": "IMMUNOGLOBULINE HUMAINE DE L'HÉPATITE B",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "solution injectable",
  "voies_administration": "sous-cutanée",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about immunoglobuline humaine de l'hépatite b.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.